News ArchivesRead News

Parkinson's event at Buck draws hundreds

Thursday September 17, 2009

Jim Welte

Contra Costa Times - Researchers told more than 250 people packed into an auditorium at the Buck Institute for Age Research on Thursday that diagnosing and treating Parkinson's disease before people display symptoms has become one of the latest movements in the scientific field.

"The Holy Grail right now is the pre-symptomatic diagnosis and treatment of Parkinson's," Buck professor Julie Andersen told the crowd. "The key thing is, 'Can we treat you before you actually show symptoms of the disease?'"

Andersen and Alison McCormack of the Parkinson's Institute in Sunnyvale described in detail the latest research by their organizations in the seminar, titled "Parkinson's Disease: From Bench to Bedside." The key, they said, is turning the latest research into clinical diagnosis and treatment for patients before they show prevalent symptoms such as hand tremors, rigidity and postural instability.

Andersen said there are no standard tests available to make a diagnosis in people before they show symptoms, but advances are being made. Much of the effort in that regard is focusing on bringing down costs for imaging tests such as MRIs that could help with early detection.

McCormack said her institute's research has shown a high prevalence for impaired sense of smell among those who eventually get Parkinson's but who have yet to display other signs of the disease.

Both professors said that aging and environmental factors such as exposure to pesticides remain the primary causes. There are more than 1.5 million people worldwide suffering from Parkinson's at a cost of $6 billion annually. The rate of contracting it jumps from 1 out of 100 for people over age 65 to 1 out of 30 for those over age 85.

Many attendees said they had Parkinson's and were hoping to learn more both about the causes and new treatments.
Judith Geri, 64, of Petaluma said that people who don't yet have Parkinson's are less likely to attend a seminar on the disease. "But most of the research we heard about today is for people that don't have Parkinson's yet," she said. "All of the new tests are for people who just started showing symptoms. What are they going to do for the people who already have it?"

Recent News

Nov 22 - A caregiver's story: Living and loving through the slow process of dying
Nov 19 - Testosterone cause of sex differences in the occurrence of Parkinson’s disease, new research suggests
Nov 18 - New strategy reduces side effects in Parkinson's treatment
Nov 14 - Opinion: The never-ending tests of Parkinson's disease
Nov 13 - Parkinson’s disease: A new tool for diagnosis
Nov 10 - Parkinson's Disease Drug May Be Useful For Delaying, Preventing Blindness In Older Population
Nov 9 - Microsoft VP’s diagnosis fuels employees’ heartfelt efforts to help others
Nov 6 - Lewy body dementia: unrecognized and misdiagnosed
Nov 5 - Gait difficulties in Parkinson's linked to new blood vessels in brain
Oct 30 - Special Section: Enabling Technologies for Parkinson’s Disease Management
Oct 27 - Scientists discover a 'switchboard' of molecules that protect against Parkinson's disease
Oct 26 - Dancing improves mobility and quality of life in people with Parkinson's
Oct 23 - The amazing woman who can smell Parkinson’s disease — before symptoms appear
Oct 20 - Personal Essay: The deviousness of dementia
Oct 19 - Mechanism that 'melts' protein clumps may lead to new Parkinson's treatments
Oct 19 - Researchers find that stem cell treatment may reduce cognitive impairment related to dementia with Lewy bodies
Oct 17 - Cancer Drug Helps Parkinson's Patients
Oct 12 - Researchers identify immune gene that can prevent Parkinson's disease and dementia
Oct 12 - Blog Post: An Alert, Well-Hydrated Artist in No Acute Distress
Oct 7 - This month, a brain surgery will be broadcast on live TV for the first time ever